Marché européen des examens de santé – Tendances et prévisions du secteur jusqu’en 2028

Demande de table des matières Demande de table des matières Parler à un analysteParler à un analyste Acheter maintenantAcheter maintenant Renseignez-vous avant d'acheterRenseignez-vous avant Exemple de rapport gratuitExemple de rapport gratuit

Marché européen des examens de santé – Tendances et prévisions du secteur jusqu’en 2028

  • Healthcare
  • Publish Reports
  • Oct 2021
  • Europe
  • 350 Pages
  • Nombre de tableaux : 339
  • Nombre de figures : 57

>Marché européen du dépistage de la santé, par type de test (tests de cholestérol, test du diabète , dépistage du cancer, test de contrôle général, MST, test de tension artérielle et autres), type d'emballage (dépistage de la santé de base, profil des personnes âgées, bilan de santé des femmes, bilan de santé des hommes, bilan cardiaque , bilan du diabète et autres), type de panel (panels multi-tests et panels à test unique), type d'échantillon (sang, urine, sérum , salive et autres), technologie (immuno-essais, imagerie médicale, QPCR (réaction en chaîne par polymérase quantitative), Q-FISH (fluorescence quantitative, hybridation in situ), TRF (fragment de restriction terminale), STELA (analyse de la longueur d'un seul télomère) et autres), état (maladie cardiovasculaire, troubles métaboliques, cancer, affections inflammatoires, troubles musculo-squelettiques, affections neurologiques, complications de l'hépatite C, affections liées à l'immunologie et autres), Sites de collecte d'échantillons (hôpitaux, domiciles, laboratoires de diagnostic, bureaux et autres), canal de distribution (appels d'offres directs, ventes au détail et autres), pays (Allemagne, France, Royaume-Uni, Hongrie, Lituanie, Autriche, Irlande, Norvège, Pologne, Italie, Espagne, Russie, Turquie, Pays-Bas, Suisse, reste de l'Europe), tendances et prévisions de l'industrie jusqu'en 2028.

Marché européen des examens de santéAnalyse et perspectives du marché : marché européen du dépistage médical

Le marché européen du dépistage de santé devrait connaître une croissance de marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 10,8 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 141 824,23 millions USD d'ici 2028. Le nombre croissant de maladies chroniques, la population gériatrique et la sensibilisation croissante à la détection et au traitement précoces des maladies sont les principaux moteurs qui ont propulsé la demande du marché au cours de la période de prévision.

Le dépistage médical est une méthode importante de détection précoce d'un trouble spécifique. Les tests de dépistage sont souvent utilisés en médecine préventive pour identifier si un individu présente des signes précoces de facteurs de risque d'une maladie. Les maladies qui peuvent être détectées par dépistage comprennent le cancer, le diabète, l'hypercholestérolémie, l'hypertension artérielle et l'ostéoporose. L'augmentation du volume des maladies chroniques, la population gériatrique et la sensibilisation croissante à la détection et au traitement précoces des maladies propulsent la croissance du marché du dépistage médical.

La sensibilisation croissante de la population à la détection et au traitement précoces des maladies ainsi que l’augmentation des dépenses de santé accroissent la demande de dépistage médical.

Rising demand for health screening because of its efficacy, growing number of service providers, and increasing awareness campaign by private and public players of health screening are propelling the growth of the health screening market in the forecast period hence acting as opportunity for the market. However, the high cost of screening test may hamper the market growth in the forecast period.

The Europe health screening market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief; our team will help you create a revenue impact solution to achieve your desired goal.

Marché européen des examens de santéEurope Health Screening Market Scope and Market Size

Europe health screening market is segmented into eight notable segments, which are based on test type, package type, panel type, sample type, technology, condition, sample collection sites, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. 

  • On the basis of test type, Europe health screening market is segmented into cholesterol tests, diabetes test, cancer screening, general checkup test, STDs, blood pressure test, and others. In 2021, cholesterol test segment is expected to dominate the market due to increase awareness about risk associated with high cholesterol level in the population.
  • On the basis of package type, the Europe health screening market is segmented into basic health screening, senior citizen profile, women health check, men health check, heart check, diabetes check, and others. In 2021, basic health screening segment is expected to dominate the market because of the various health program organized by the government and by the service providers.
  • On the basis of panel type, Europe health screening market is segmented into multi-test panels and single-test panels. In 2021, multi-test panels segment is expected to dominate the market due to advancement in multi test panel for detecting various diseases at a small interval of time.
  • On the basis of sample type, the Europe health screening market is segmented into blood, urine, serum, saliva, and others. In 2021, blood segment is expected to dominate the market because blood test can help identify how well the organs are working such as heart, kidneys, and liver among others.
  • Sur la base de la technologie, le marché européen du dépistage médical est segmenté en immuno-essais, imagerie médicale, QPCR (Quantitative Polymerase Chain Reaction), Q-FISH (Quantitative Fluorescence, hybridation in situ), TRF (Terminal Restriction Fragment), STELA (Single Telomere Length Analysis) et autres. En 2021, le segment des immuno-essais devrait dominer le marché car les immuno-essais contribuent à l'approbation de divers nouveaux produits de dépistage dans la région, ce qui tend à augmenter la taille du marché en Europe.
  • Sur la base des conditions, le marché européen du dépistage médical est segmenté en maladies cardiovasculaires, troubles métaboliques, cancer, maladies inflammatoires, troubles musculo-squelettiques, maladies neurologiques, complications de l'hépatite C, maladies liées à l'immunologie, etc. En 2021, le segment des maladies cardiovasculaires devrait dominer le marché en raison de la forte prévalence des maladies cardiovasculaires dans la région européenne
  • Sur la base des sites de collecte d'échantillons, le marché européen du dépistage médical est segmenté en hôpitaux, maisons, laboratoires de diagnostic, bureaux et autres. En 2021, le segment des hôpitaux devrait dominer le marché en raison des services de santé centrés sur le patient en Europe
  • Sur la base du canal de distribution, le marché européen du dépistage médical est segmenté en appels d'offres directs, ventes au détail et autres. En 2021, le segment des appels d'offres directs devrait dominer le marché de la majorité des acteurs du marché opérant directement dans la région européenne

Analyse du marché des examens de santé en Europe au niveau des pays

Le marché européen du dépistage sanitaire est analysé et des informations sur la taille du marché sont fournies sur le type de test, le type d’emballage, le type de panel, le type d’échantillon, la technologie, l’état, les sites de collecte d’échantillons et le canal de distribution.

Les pays couverts par le rapport sur le marché européen du dépistage médical sont la France, le Royaume-Uni, l'Italie, l'Allemagne, l'Espagne, la Russie, la Turquie, les Pays-Bas, la Suisse, la Belgique et le reste de l'Europe. L'Allemagne dans la région européenne devrait connaître le taux de croissance le plus élevé au cours de la période de prévision de 2021 à 2028 en raison de l'approbation croissante des produits de dépistage dans la région européenne et de l'augmentation de la population gériatrique.

La section par pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements dans la réglementation du marché qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie des pays, les actes réglementaires et les tarifs d'importation et d'exportation sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques européennes et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des canaux de vente sont pris en compte tout en fournissant une analyse prévisionnelle des données nationales.

Croissance de la population gériatrique et approbation des produits dans le cadre d'une croissance plus importante du marché européen du dépistage médical

Le marché européen du dépistage de santé vous fournit également une analyse de marché détaillée de la croissance de chaque pays dans le secteur des produits de dépistage avec les ventes de produits, l'impact des progrès, la technologie et les changements dans les scénarios réglementaires avec leur soutien au marché du dépistage de santé. Les données sont disponibles pour la période historique de 2010 à 2019.  

Analyse du paysage concurrentiel et des parts de marché du dépistage médical en Europe

Le paysage concurrentiel du marché européen du dépistage médical fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, les sites et installations de production, les forces et les faiblesses de l'entreprise, le lancement de produits, les pipelines d'essais de produits, les approbations de produits, les brevets, la largeur et l'étendue du produit, la domination des applications, la courbe de survie technologique. Les points de données ci-dessus ne concernent que l'orientation de l'entreprise vers le marché européen du dépistage médical.

Français Les principales entreprises qui opèrent sur le marché européen du dépistage médical sont Sonic Healthcare Limited, Quest Diagnostics Incorporated, Healius Limited, Eurofins Scientific, GRAIL, , Exact Sciences Corporation, SYNLAB International GmbH, UNILABS, LabPLUS, BioReference Laboratories, , ACM Global Laboratories, Cerba Healthcare, Quidel Corporation, Innova Medical Group, AMEDES Holding GmbH, RadNet, Inc., Natera, Inc., Trinity Biotech, Nuffield Health, RepeatDx, NeoGenomics Laboratories, HU Group Holdings, Inc., Lifelabs, ARUP Laboratories, Q2 Solutions, Genova Diagnostics, Life Length, DNA Labs India, , Telomere Diagnostics, Charles River Laboratories, Ambry Genetics, SpectraCell Laboratories, Inc., Dr. Lal PathLabs et Laboratory Corporation of America, entre autres.

De nombreux événements, webinaires et accords sont également initiés par des entreprises du monde entier, ce qui accélère également le marché européen du dépistage médical.

Par exemple,

  • En septembre 2021, Eurofins Scientific a annoncé que sa filiale Transplant Genomics avait lancé Omnigraf, le seul panel de biomarchés combinés qui fournit l'indication la plus précoce du rejet chez les receveurs de greffe de rein. Cela permettra d'élargir le portefeuille de produits de l'entreprise
  • En octobre 2018, Eurofins Scientific a annoncé l'acquisition d'EnvironeX Group Inc. (EnvironeX) auprès de Marc Hamilton et Persistence Capital Partners. Cette acquisition permettra à l'entreprise d'accroître ses capacités de test.

Les événements, les publications, les accords et d’autres stratégies des acteurs du marché améliorent le marché des entreprises sur le marché du traitement du syndrome de Hunter, ce qui profite également aux organisations pour améliorer leur offre de services de dépistage de santé.


SKU-

Accédez en ligne au rapport sur le premier cloud mondial de veille économique

  • Tableau de bord d'analyse de données interactif
  • Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
  • Accès d'analyste de recherche pour la personnalisation et les requêtes
  • Analyse de la concurrence avec tableau de bord interactif
  • Dernières actualités, mises à jour et analyse des tendances
  • Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Demande de démonstration

Table des matières

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF EUROPE HEALTH SCREENING MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 TEST TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 DISTRIBUTION CHANNELUSER COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 REGULATIONS

5.1 WORLD HEALTH ORGANIZATION

5.2 NORTH AMERICA

5.3 EUROPE

6 INDUSTRIAL INSIGHTS

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 RISING PREVALENCE OF CHRONIC DISEASES

7.1.2 GROWING GERIATRIC POPULATION

7.1.3 GOVERNMENT INITIATIVES UNDERTAKEN TO IMPLEMENT SCREENING PROGRAMS FOR VARIOUS DISEASES

7.1.4 RISING PER CAPITA INCOME AND HEALTHCARE EXPENDITURE

7.1.5 GRWOING NUMBER OF SCREENING PROGRAMS WORLDWIDE

7.2 RESTRAINTS

7.2.1 SCRACITY OF TECHNICALLY-SKILLED PROFESSIONALS

7.2.2 RISKS ASSOCIATED WITH SCREENING

7.2.3 LACK OF ACCESSIBILITY

7.3 OPPORTUNITIES

7.3.1 TECHNOLOGICAL ADVANCEMENTS IN HEALTH SCREENING

7.3.2 ACQUSITIONS AND MERGERS AMONG THE MARKET

7.3.3 NEW PRODUCT LAUNCHES IN THE MARKET

7.4 CHALLENGES

7.4.1 HIGHER COST OF HEALTH SCREENING

7.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING SCREENING TESTS

8 COVID-19 IMPACT ON EUROPE HEALTH SCREENING MARKET

8.1 PRICE IMPACT

8.2 IMPACT ON DEMAND

8.3 IMPACT ON SUPPLY CHAIN

8.4 STRATEGIC DECISIONS FOR MANUFACTURERS

8.5 CONCLUSION

9 EUROPE HEALTH SCREENING MARKET, BY TEST TYPE

9.1 OVERVIEW

9.2 CHOLESTEROL TESTS

9.2.1 TOTAL CHOLESTEROL TESTS

9.2.2 TRIGLYCERIDES

9.2.3 LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL

9.2.4 HIGH-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL

9.3 DIABETES TEST

9.3.1 FASTING/RANDOM BLOOD SUGAR TEST

9.3.2 A1C TEST

9.3.3 GLUCOSE TOLERANCE TEST

9.4 CANCER SCREENING

9.4.1 LIQUID BIOPSY

9.4.2 MAMMOGRAMS, OSTEOPOROSIS, BREAST MRI AND PAP SMEAR TESTS

9.4.3 LOW-DOSE HELICAL COMPUTED TOMOGRAPHY

9.4.4 COLORECTAL CANCER SCREENING TEST (STOOL TESTS, SIGMOIDOSCOPY, COLONOSCOPY, BLOOD-BASED DNA TEST, DOUBLE-CONTRAST BARIUM ENEMA (DCBE), AND SINGLE-SPECIMEN GFOBT)

9.4.5 PROSTATE SPECIFIC ANTIGEN (PSA) TEST

9.4.6 NEW-EARLY DETECTION CANCER TESTS

9.4.7 ALPHA FETOPROTEIN BLOOD TEST

9.4.8 CA-125 TEST

9.4.9 OTHERS

9.5 GENERAL CHECK UP TEST

9.5.1 REGULAR CHECK UP

9.5.1.1 REGULAR BLOOD TEST

9.5.1.2 X-RAYS

9.5.1.3 ECG

9.5.1.4 FECALYSIS

9.5.1.5 URINALYSIS

9.5.1.6 BMI

9.5.1.7 OTHERS

9.5.2 EYE CHECK UP

9.5.3 DENTAL TEST

9.5.4 HEARING TEST

9.6 STD’S

9.6.1 CHLAMYDIA

9.6.2 GONORRHEA

9.6.3 HPV

9.6.4 HIV

9.6.5 OTHERS

9.7 BLOOD PRESSURE TEST

9.8 OTHERS

9.8.1 LIVER FUNCTION TESTS

9.8.2 KIDNEY PROFILE

9.8.3 OTHERS

10 EUROPE HEALTH SCREENING MARKET, BY PANEL TYPE

10.1 OVERVIEW

10.2 MULTI-TEST PANELS

10.3 SINGLE-TEST PANELS

10.3.1 INFLAMMATION TESTS

10.3.2 OXIDATIVE STRESS TESTS

10.3.3 HEAVY METAL TESTS

10.3.4 TELOMERE

11 EUROPE HEALTH SCREENING MARKET, BY PACKAGE TYPE

11.1 OVERVIEW

11.2 BASIC HEALTH SCREENING

11.3 SENIOR CITIZEN PROFILE

11.4 WOMEN HEALTH CHECK

11.5 MEN HEALTH CHECK

11.6 HEART CHECK

11.7 DIABETES CHECK

11.8 OTHERS

12 EUROPE HEALTH SCREENING MARKET, BY SAMPLE TYPE

12.1 OVERVIEW

12.2 BLOOD

12.3 URINE

12.4 SERUM

12.5 SALIVA

12.6 OTHERS

13 HEALTH SCREENING MARKET, BY TECHNOLOGY

13.1 OVERVIEW

13.2 IMMUNOASSAYS

13.3 MEDICAL IMAGING

13.4 QPCR

13.4.1 MMQPCR (MONOCHROME MULTIPLEX QPCR)

13.4.2 ATLQPCR (ABSOLUTE TELOMERE LENGTH QPCR)

13.5 Q-FISH

13.5.1 PRINS (PRIMED IN SITU SUBTYPE OF Q-FISH)

13.5.2 FLOW-FISH

13.5.3 HT Q-FISH (HIGH THROUGHPUT Q-FISH)

13.6 TRF (TERMINAL RESTRICTION FRAGMENT)

13.7 STELA (SINGLE TELOMERE LENGTH ANALYSIS)

13.8 OTHERS

14 EUROPE HEALTH SCREENING MARKET, BY CONDITION

14.1 OVERVIEW

14.2 CARDIOVASCULAR DISEASE

14.2.1 CORONARY HEART DISEASE

14.2.2 ATHEROSCLEROSIS

14.3 METABOLIC DISORDERS

14.3.1 DIABETES MELLITUS

14.3.2 OBESITY

14.4 CANCER

14.5 INFLAMMATORY CONDITIONS

14.5.1 AUTOIMMUNE CONDITIONS

14.5.2 ALLERGIES

14.5.3 ARTHRITIS

14.5.4 ASTHMA

14.5.5 INFLAMMATORY DIGESTIVE PROBLEMS

14.6 MUSCULOSKELETAL DISORDERS

14.6.1 OSTEOPOROSIS

14.6.2 RHEUMATOID ARTHRITIS

14.7 NEUROLOGICAL CONDITIONS

14.7.1 CHRONIC STRESS

14.7.2 ALZHEIMER'S DISEASE

14.8 IMMUNOLOGY-RELATED CONDITIONS

14.9 HEPATITIS C COMPLICATIONS

14.1 OTHERS

15 HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL

15.1 OVERVIEW

15.2 DIRECT TENDERS

15.3 RETAIL SALES

15.4 OTHERS

16 EUROPE HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES

16.1 OVERVIEW

16.2 HOSPITAL

16.2.1 ACUTE CARE HOSPITALS

16.2.2 LONG-TERM CARE HOSPITALS

16.2.3 NURSING FACILITIES

16.2.4 REHABILITATION CENTERS

16.3 HOME

16.4 DIAGNOSTIC LABORATORIES

16.5 OFFICES

16.6 OTHERS

17 EUROPE HEALTH SCREENING MARKET, BY REGION

17.1 EUROPE

17.1.1 GERMANY

17.1.2 FRANCE

17.1.3 UNITED KINGDOM

17.1.4 ITALY

17.1.5 RUSSIA

17.1.6 SPAIN

17.1.7 TURKEY

17.1.8 BELGIUM

17.1.9 NETHERLANDS

17.1.10 SWITZERLAND

17.1.11 REST OF EUROPE

18 EUROPE HEALTH SCREENING MARKET: COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: EUROPE

19 SWOT ANALYSIS

20 COMPANY PROFILE

20.1 QUEST DIAGNOSTICS INCORPORATED

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 COMPANY SHARE ANALYSIS

20.1.4 PRODUCT PORTFOLIO

20.1.5 RECENT DEVELOPMENTS

0.2 SONIC HEALTHCARE LIMITED

20.2.1 COMPANY SNAPSHOT

20.2.2 REVENUE ANALYSIS

20.2.3 COMPANY SHARE ANALYSIS

20.2.4 PRODUCT PORTFOLIO

20.2.5 RECENT DEVELOPMENTS

20.3 LABORATORY CORPORATION OF AMERICA

20.3.1 COMPANY SNAPSHOT

20.3.2 REVENUE ANALYSIS

20.3.3 COMPANY SHARE ANALYSIS

20.3.4 PRODUCT PORTFOLIO

20.3.5 RECENT DEVELOPMENT

20.4 EUROFINS SCIENTIFIC

20.4.1 COMPANY SNAPSHOT

20.4.2 REVENUE ANALYSIS

20.4.3 COMPANY SHARE ANALYSIS

20.4.4 PRODUCT PORTFOLIO

20.4.5 RECENT DEVELOPMENTS

20.5 EXACT SCIENCES CORPORATION

20.5.1 COMPANY SNAPSHOT

20.5.2 REVENUE ANALYSIS

20.5.3 COMPANY SHARE ANALYSIS

20.5.4 PRODUCT PORTFOLIO

20.5.5 RECENT DEVELOPMENTS

20.6 ACM EUROPE LABORATORIES

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENT

20.7 AMEDES

20.7.1 COMPANY SNAPSHOT

20.7.2 PRODUCT PORTFOLIO

20.7.3 RECENT DEVELOPMENT

20.8 AMBRY GENETICS

20.8.1 COMPANY SNAPSHOT

20.8.2 SERVICE PORTFOLIO

20.8.3 RECENT DEVELOPMENTS

20.9 ARUP LABORATORIES

20.9.1 COMPANY SNAPSHOT

20.9.2 PRODUCT PORTFOLIO

20.9.3 RECENT DEVELOPMENTS

20.1 BIOREFRENCE LABORATORIES

20.10.1 COMPANY SNAPSHOT

20.10.2 REVENUE ANALYSIS

20.10.3 PRODUCT PORTFOLIO

20.10.4 RECENT DEVELOPMENTS

20.11 CHARLES RIVER

20.11.1 COMPANY SNAPSHOT

20.11.2 REVENUE ANALYSIS

20.11.3 PRODUCT PORTFOLIO

20.11.4 RECENT DEVELOPMENTS

20.12 CERBA HEALTHCARE

20.12.1 COMPANY SNAPSHOT

20.12.2 PRODUCT PORTFOLIO

20.12.3 RECENT DEVELOPMENT

20.13 DNA LABS INDIA

20.13.1 COMPANY SNAPSHOT

20.13.2 SERVICE PORTFOLIO

20.13.3 RECENT DEVELOPMENT

20.14 DR LAL PATH LABS

20.14.1 COMPANY SNAPSHOT

20.14.2 REVENUE ANALYSIS

20.14.3 PRODUCT PORTFOLIO

20.14.4 RECENT DEVELOPMENT

20.15 GENOVA DIGNOSTICS

20.15.1 COMPANY SNAPSHOT

20.15.2 SERVICE PORTFOLIO

20.15.3 RECENT DEVELOPMENT

20.16 GRAIL

20.16.1 COMPANY SNAPSHOT

20.16.2 SERVICE PORTFOLIO

20.16.3 RECENT DEVELOPMENTS

20.17 HEALIUS LIMITED

20.17.1 COMPANY SNAPSHOT

20.17.2 REVENUE ANALYSIS

20.17.3 PRODUCT PORTFOLIO

20.17.4 RECENT DEVELOPMENTS

20.18 H.U. GROUP HOLDINGS, INC.

20.18.1 COMPANY SNAPSHOT

20.18.2 REVENUE ANALYSIS

20.18.3 PRODUCT PORTFOLIO

20.18.4 RECENT DEVELOPMENTS

20.19 INNOVA MEDICAL GROUP

20.19.1 COMPANY SNAPSHOT

20.19.2 PRODUCT PORTFOLIO

20.19.3 RECENT DEVELOPMENT

20.2 LABPLUS

20.20.1 COMPANY SNAPSHOT

20.20.2 PRODUCT PORTFOLIO

20.20.3 RECENT DEVELOPMENT

20.21 LIFELABS

20.21.1 COMPANY SNAPSHOT

20.21.2 SERVICE PORTFOLIO

20.21.3 RECENT DEVELOPMENTS

20.22 LIFE LENGTH

20.22.1 COMPANY SNAPSHOT

20.22.2 SERVICE PORTFOLIO

20.22.3 RECENT DEVELOPMENT

20.23 NATERA, INC.

20.23.1 COMPANY SNAPSHOT

20.23.2 REVENUE ANALYSIS

20.23.3 PRODUCT PORTFOLIO

20.23.4 RECENT DEVELOPMENTS

20.24 NEOGENOMICS LABORATORIES

20.24.1 COMPANY SNAPSHOT

20.24.2 REVENUE ANALYSIS

20.24.3 PRODUCT PORTFOLIO

20.24.4 RECENT DEVELOPMENTS

20.25 NUFFIELD HEALTH

20.25.1 COMPANY SNAPSHOT

20.25.2 PRODUCT PORTFOLIO

20.25.3 RECENT DEVELOPMENT

20.26 Q2 SOLUTIONS

20.26.1 COMPANY SNAPSHOT

20.26.2 SERVICE PORTFOLIO

20.26.3 RECENT DEVELOPMENTS

20.27 QUIDEL CORPORATION

20.27.1 COMPANY SNAPSHOT

20.27.2 REVENUE ANALYSIS

20.27.3 PRODUCT PORTFOLIO

20.27.4 RECENT DEVELOPMENTS

20.28 REPEATDX

20.28.1 COMPANY SNAPSHOT

20.28.2 PRODUCT PORTFOLIO

20.28.3 RECENT DEVELOPMENT

20.29 SONIC HEALTHCARE LIMITED

20.29.1 COMPANY SNAPSHOT

20.29.2 REVENUE ANALYSIS

20.29.3 PRODUCT PORTFOLIO

20.29.4 RECENT DEVELOPMENTS

20.3 SPECTRACELL LABORATORIES, INC.

20.30.1 COMPANY SNAPSHOT

20.30.2 SERVICE PORTFOLIO

20.30.3 RECENT DEVELOPMENT

20.31 SYNLAB INTERNATIONAL GMBH

20.31.1 COMPANY SNAPSHOT

20.31.2 PRODUCT PORTFOLIO

20.31.3 RECENT DEVELOPMENT

20.32 TELOMERE DIAGNOSTICS

20.32.1 COMPANY SNAPSHOT

20.32.2 SERVICE PORTFOLIO

20.32.3 RECENT DEVELOPMENT

20.33 TRINITY BIOTECH

20.33.1 COMPANY SNAPSHOT

20.33.2 REVENUE ANALYSIS

20.33.3 PRODUCT PORTFOLIO

20.33.4 RECENT DEVELOPMENT

20.34 UNILABS

20.34.1 COMPANY SNAPSHOT

20.34.2 PRODUCT PORTFOLIO

20.34.3 RECENT DEVELOPMENT

21 QUESTIONNAIRE

22 RELATED REPORTS

Liste des tableaux

TABLE 1 NUMBER OF PEOPLE WITH DIABETES AMONG 20–79 YEARS OLD (IN MILLION)

TABLE 2 NEW CANCER CASES FOR AGE 85+ IN U.S.

TABLE 3 ACCORDING TO THE UNITED NATIONS, IN 2019, THE TOTAL POPULATION OF AGED PEOPLE ABOVE 65 WAS 703 MILLION AND IS EXPECTED TO REACH 1.5 BILLION BY 2050.

TABLE 4 PER CAPITA AMOUNTS: THE UNITED STATES (1960–2017)

TABLE 5 EUROPE HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 6 EUROPE CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 7 EUROPE CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 8 EUROPE DIABETES TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 9 EUROPE DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 10 EUROPE CANCER SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 11 EUROPE CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 12 EUROPE GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 13 EUROPE GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 14 EUROPE REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 15 EUROPE STD’S IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 16 EUROPE STD’S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 17 EUROPE BLOOD PRESSURE TEST IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 EUROPE OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 19 EUROPE OTHERS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 20 EUROPE HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 21 EUROPE MULTI-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 22 EUROPE SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 EUROPE SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 24 EUROPE HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 25 EUROPE BASIC HEALTH SCREENING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 26 EUROPE SENIOR CITIZEN PROFILE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 EUROPE WOMEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 28 EUROPE MEN HEALTH CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 EUROPE HEART CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 30 EUROPE DIABETES CHECK IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 31 EUROPE OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 EUROPE HEALTH SCREENING MARKET, BY SAMPLE TYPE, 2019-2028 (USD MILLION)

TABLE 33 EUROPE BLOOD IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 EUROPE URINE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 35 EUROPE SERUM IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 36 EUROPE SALIVA IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 37 EUROPE OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 38 EUROPE HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 39 EUROPE IMMUNOASSAYS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 40 EUROPE MEDICAL IMAGING IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 41 EUROPE QPCR IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 42 EUROPE QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 43 EUROPE Q-FISH IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 44 EUROPE Q-FISH IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 45 EUROPE TRF (TERMINAL RESTRICTION FRAGMENT) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 46 EUROPE STELA (SINGLE TELOMERE LENGTH ANALYSIS) IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 47 EUROPE OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 48 EUROPE HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 49 EUROPE CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 50 EUROPE CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 51 EUROPE METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 52 EUROPE METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 53 EUROPE CANCER IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 54 EUROPE INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 55 EUROPE INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 56 EUROPE MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 57 EUROPE MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 58 EUROPE NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 59 EUROPE NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 60 EUROPE IMMUNOLOGY-RELATED CONDITIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 61 EUROPE HEPATITIS-C COMPLICATIONS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 62 EUROPE OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 63 EUROPE HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 64 EUROPE DIRECT TENDERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 65 EUROPE RETAIL SALES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 66 EUROPE OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 67 EUROPE HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 68 EUROPE HOSPITAL IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 69 EUROPE HOSPITAL IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 70 EUROPE HOME IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 71 EUROPE DIAGNOSTIC LABORATORIES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 72 EUROPE OFFICES IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 73 EUROPE OTHERS IN HEALTH SCREENING MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 74 EUROPE HEALTH SCREENING MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 75 EUROPE HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 76 EUROPE CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 77 EUROPE DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 78 EUROPE CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 79 EUROPE GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION

TABLE 80 EUROPE REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 81 EUROPE STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 82 EUROPE OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 83 EUROPE HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION

TABLE 84 EUROPE HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 85 EUROPE SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 86 EUROPE HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 87 EUROPE HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 88 EUROPE QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 89 EUROPE Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION

TABLE 90 EUROPE HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 91 EUROPE CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 92 EUROPE METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 93 EUROPE INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 94 EUROPE MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 95 EUROPE NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 96 EUROPE HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 97 EUROPE HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 98 EUROPE HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 99 GERMANY HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 100 GERMANY CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 101 GERMANY DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 102 GERMANY CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 103 GERMANY GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 104 GERMANY REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 105 GERMANY STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 106 GERMANY OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 107 GERMANY HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 108 GERMANY HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 109 GERMANY SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 110 GERMANY HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 111 GERMANY HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 112 GERMANY QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 113 GERMANY Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 114 GERMANY HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 115 GERMANY CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 116 GERMANY METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 117 GERMANY INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 118 GERMANY MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 119 GERMANY NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 120 GERMANY HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 121 GERMANY HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 122 GERMANY HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 123 FRANCE HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 124 FRANCE CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 125 FRANCE DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 126 FRANCE CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 127 FRANCE GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 128 FRANCE REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 129 FRANCE STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 130 FRANCE OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 131 FRANCE HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 132 FRANCE HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 133 FRANCE SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 134 FRANCE HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 135 FRANCE HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 136 FRANCE QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 137 FRANCE Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 138 FRANCE HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 139 FRANCE CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 140 FRANCE METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 141 FRANCE INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 142 FRANCE MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 143 FRANCE NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 144 FRANCE HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 145 FRANCE HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 146 FRANCE HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 147 UNITED KINGDOM HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 148 UNITED KINGDOM CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 149 UNITED KINGDOM DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 150 UNITED KINGDOM CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 151 UNITED KINGDOM GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 152 UNITED KINGDOM REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION

TABLE 153 UNITED KINGDOM STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 154 UNITED KINGDOM OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 155 UNITED KINGDOM HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 156 UNITED KINGDOM HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 157 UNITED KINGDOM SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 158 UNITED KINGDOM HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 159 UNITED KINGDOM HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 160 UNITED KINGDOM QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 161 UNITED KINGDOM Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 162 UNITED KINGDOM HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 163 UNITED KINGDOM CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 164 UNITED KINGDOM METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 165 UNITED KINGDOM INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 166 UNITED KINGDOM MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 167 UNITED KINGDOM NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 168 UNITED KINGDOM HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 169 UNITED KINGDOM HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 170 UNITED KINGDOM HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 171 ITALY HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 172 ITALY CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 173 ITALY DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 174 ITALYCANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 175 ITALY GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 176 ITALY REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 177 ITALY STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 178 ITALY OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 179 ITALY HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 180 ITALY HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 181 ITALY SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 182 ITALY HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 183 ITALY HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 184 ITALY QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 185 ITALY Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 186 ITALY HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 187 ITALY CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 188 ITALY METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 189 ITALY INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 190 ITALY MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 191 ITALY NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 192 ITALYHEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 193 ITALY HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 194 ITALY HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 195 RUSSIA HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 196 RUSSIA CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 197 RUSSIA DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 198 RUSSIA CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 199 RUSSIA GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 200 RUSSIA REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 201 RUSSIA STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 202 RUSSIA OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 203 RUSSIA HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 204 RUSSIA HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 205 RUSSIA SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 206 RUSSIA HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 207 RUSSIA HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 208 RUSSIA QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 209 RUSSIA Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 210 RUSSIA HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 211 RUSSIA CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 212 RUSSIA METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 213 RUSSIA INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 214 RUSSIA MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 215 RUSSIA NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 216 RUSSIA HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 217 RUSSIA HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 218 RUSSIA HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 219 SPAIN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 220 SPAIN CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 221 SPAIN DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 222 SPAIN CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 223 SPAIN GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 224 SPAIN REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 225 SPAIN STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 226 SPAIN OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 227 SPAIN HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 228 SPAIN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 229 SPAIN SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 230 SPAIN HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 231 SPAIN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 232 SPAIN QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 233 SPAIN Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 234 SPAINHEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 235 SPAIN CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 236 SPAIN METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 237 SPAIN INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 238 SPAIN MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 239 SPAIN NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 240 SPAIN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 241 SPAIN HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 242 SPAIN HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 243 TURKEY HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 244 TURKEY CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 245 TURKEY DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 246 TURKEY CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 247 TURKEY GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 248 TURKEY REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 249 TURKEY STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 250 TURKEY OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 251 TURKEY HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 252 TURKEY HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 253 TURKEY SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 254 TURKEY HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 255 TURKEY HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 256 TURKEY QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 257 TURKEY Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 258 TURKEY HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 259 TURKEY CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 260 TURKEY METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 261 TURKEY INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 262 TURKEY MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 263 TURKEY NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 264 TURKEY HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 265 TURKEY HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 266 TURKEY HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 267 BELGIUM HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 268 BELGIUM CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 269 BELGIUM DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 270 BELGIUM CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 271 BELGIUM GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 272 BELGIUM REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 273 BELGIUM STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 274 BELGIUM OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 275 BELGIUM HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 276 BELGIUM HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 277 BELGIUM SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 278 BELGIUM HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 279 BELGIUM HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 280 BELGIUM QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 281 BELGIUM Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 282 BELGIUM HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 283 BELGIUM CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 284 BELGIUM METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 285 BELGIUM INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 286 BELGIUM MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 287 BELGIUM NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 288 BELGIUM HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 289 BELGIUM HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 290 BELGIUM HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 291 NETHERLANDS HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 292 NETHERLANDS CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 293 NETHERLANDS DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 294 NETHERLANDS CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 295 NETHERLANDS GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 296 NETHERLANDS REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 297 NETHERLANDS STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 298 NETHERLANDS OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 299 NETHERLANDS HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 300 NETHERLANDS HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 301 NETHERLANDS SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 302 NETHERLANDS HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 303 NETHERLANDS HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 304 NETHERLANDS QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 305 NETHERLANDS Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 306 NETHERLANDS HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 307 NETHERLANDS CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 308 NETHERLANDS METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 309 NETHERLANDS INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 310 NETHERLANDS MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 311 NETHERLANDS NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 312 NETHERLANDS HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 313 NETHERLANDS HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 314 NETHERLANDS HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 315 SWITZERLAND HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 316 SWITZERLAND CHOLESTEROL TESTS IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 317 SWITZERLAND DIABETES TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 318 SWITZERLAND CANCER SCREENING IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 319 SWITZERLAND GENERAL CHECK UP TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 320 SWITZERLAND REGULAR CHECK UP IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 321 SWITZERLAND STD'S IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 322 SWITZERLAND OTHER TEST IN HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

TABLE 323 SWITZERLAND HEALTH SCREENING MARKET, BY PACKAGE TYPE, 2019-2028 (USD MILLION)

TABLE 324 SWITZERLAND HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 325 SWITZERLAND SINGLE-TEST PANELS IN HEALTH SCREENING MARKET, BY PANEL TYPE, 2019-2028 (USD MILLION)

TABLE 326 SWITZERLAND HEALTH SCREENING MARKET, BY SAMPLE TYPES, 2019-2028 (USD MILLION)

TABLE 327 SWITZERLAND HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 328 SWITZERLAND QPCR IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 329 SWITZERLAND Q-FISH (QUANTITATIVE FLUORESCENCE IN SITU HYBRIDIZATION) IN HEALTH SCREENING MARKET, BY TECHNOLOGY, 2019-2028 (USD MILLION)

TABLE 330 SWITZERLAND HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 331 SWITZERLAND CARDIOVASCULAR DISEASE IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 332 SWITZERLAND METABOLIC DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 333 SWITZERLAND INFLAMMATORY CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 334 SWITZERLAND MUSCULOSKELETAL DISORDERS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 335 SWITZERLAND NEUROLOGICAL CONDITIONS IN HEALTH SCREENING MARKET, BY CONDITION, 2019-2028 (USD MILLION)

TABLE 336 SWITZERLAND HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 337 SWITZERLAND HOSPITALS IN HEALTH SCREENING MARKET, BY SAMPLE COLLECTION SITES, 2019-2028 (USD MILLION)

TABLE 338 SWITZERLAND HEALTH SCREENING MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 339 REST OF EUROPE HEALTH SCREENING MARKET, BY TEST TYPE, 2019-2028 (USD MILLION)

Liste des figures

FIGURE 1 EUROPE HEALTH SCREENING MARKET: SEGMENTATION

FIGURE 2 EUROPE HEALTH SCREENING MARKET: DATA TRIANGULATION

FIGURE 3 EUROPE HEALTH SCREENING MARKET: DROC ANALYSIS

FIGURE 4 EUROPE HEALTH SCREENING MARKET : EUROPE VS REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE HEALTH SCREENING MARKET : COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE HEALTH SCREENING MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 EUROPE HEALTH SCREENING MARKET: DBMR MARKET POSITION GRID

FIGURE 8 EUROPE HEALTH SCREENING MARKET: MARKET DISTRIBUTION CHANNEL COVERAGE GRID

FIGURE 9 EUROPE HEALTH SCREENING MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE HEALTH SCREENING MARKET: SEGMENTATION

FIGURE 11 HIGH PREVALENCE OF CHRONIC DISEASES IS EXPECTED TO DRIVE THE EUROPE HEALTH SCREENING MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 CHOLESTROL TESTS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE HEALTH SCREENING MARKET IN 2021 & 2028

FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE HEALTH SCREENING MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF EUROPE HEALTH SCREENING MARKET

FIGURE 15 PREVALENCE OF CHRONIC DISEASES

FIGURE 16 AGING POPULATION IN THE WORLD (IN MILLION)

FIGURE 17 NORTH AMERICA AGING POPULATION (IN MILLION)

FIGURE 18 EUROPE AGING POPULATION (IN MILLION)

FIGURE 19 ASIA-PACIFIC AGING POPULATION (IN MILLION)

FIGURE 20 EUROPE HEALTH SCREENING MARKET: BY TEST TYPE, 2020

FIGURE 21 EUROPE HEALTH SCREENING MARKET: BY TEST TYPE, 2021-2028 (USD MILLION)

FIGURE 22 EUROPE HEALTH SCREENING MARKET: BY TEST TYPE, CAGR (2021-2028)

FIGURE 23 EUROPE HEALTH SCREENING MARKET: BY TEST TYPE, LIFELINE CURVE

FIGURE 24 EUROPE HEALTH SCREENING MARKET: BY PANEL TYPE, 2020

FIGURE 25 EUROPE HEALTH SCREENING MARKET: BY PANEL TYPE, 2021-2028 (USD MILLION)

FIGURE 26 EUROPE HEALTH SCREENING MARKET: BY PANEL TYPE, CAGR (2021-2028)

FIGURE 27 EUROPE HEALTH SCREENING MARKET: BY PANEL TYPE, LIFELINE CURVE

FIGURE 28 EUROPE HEALTH SCREENING MARKET: BY PACKAGE TYPE, 2020

FIGURE 29 EUROPE HEALTH SCREENING MARKET: BY PACKAGE TYPE, 2021-2028 (USD MILLION)

FIGURE 30 EUROPE HEALTH SCREENING MARKET: BY PACKAGE TYPE, CAGR (2021-2028)

FIGURE 31 EUROPE HEALTH SCREENING MARKET: BY PACKAGE TYPE, LIFELINE CURVE

FIGURE 32 EUROPE HEALTH SCREENING MARKET: BY SAMPLE TYPE, 2020

FIGURE 33 EUROPE HEALTH SCREENING MARKET: BY SAMPLE TYPE, 2021-2028 (USD MILLION)

FIGURE 34 EUROPE HEALTH SCREENING MARKET: BY SAMPLE TYPE, CAGR (2021-2028)

FIGURE 35 EUROPE HEALTH SCREENING MARKET: BY SAMPLE TYPE, LIFELINE CURVE

FIGURE 36 EUROPE HEALTH SCREENING MARKET: BY TECHNOLOGY, 2020

FIGURE 37 EUROPE HEALTH SCREENING MARKET: BY TECHNOLOGY, 2021-2028 (USD MILLION)

FIGURE 38 EUROPE HEALTH SCREENING MARKET: BY TECHNOLOGY, CAGR (2021-2028)

FIGURE 39 EUROPE HEALTH SCREENING MARKET: BY TECHNOLOGY, LIFELINE CURVE

FIGURE 40 EUROPE HEALTH SCREENING MARKET: BY CONDITION, 2020

FIGURE 41 EUROPE HEALTH SCREENING MARKET: BY CONDITION, 2021-2028 (USD MILLION)

FIGURE 42 EUROPE HEALTH SCREENING MARKET: BY CONDITION, CAGR (2021-2028)

FIGURE 43 EUROPE HEALTH SCREENING MARKET: BY CONDITION, LIFELINE CURVE

FIGURE 44 EUROPE HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 45 EUROPE HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 46 EUROPE HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 47 EUROPE HEALTH SCREENING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 48 EUROPE HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, 2020

FIGURE 49 EUROPE HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, 2021-2028 (USD MILLION)

FIGURE 50 EUROPE HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, CAGR (2021-2028)

FIGURE 51 EUROPE HEALTH SCREENING MARKET: BY SAMPLE COLLECTION SITES, LIFELINE CURVE

FIGURE 52 EUROPE HEALTH SCREENING MARKET: SNAPSHOT (2020)

FIGURE 53 EUROPE HEALTH SCREENING MARKET: BY COUNTRY (2020)

FIGURE 54 EUROPE HEALTH SCREENING MARKET: BY COUNTRY (2021 & 2028)

FIGURE 55 EUROPE HEALTH SCREENING MARKET: BY COUNTRY (2020 & 2028)

FIGURE 56 EUROPE HEALTH SCREENING MARKET: BY TEST TYPE (2021-2028)

FIGURE 57 EUROPE HEALTH SCREENING MARKET: COMPANY SHARE 2020(%)

Voir les informations détaillées Right Arrow

Méthodologie de recherche

La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.